Clinical trials for Epidermolysis bullosa

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Epidermolysis bullosa. For all clinical trials, go to clinical trials search

This list shows clinical trials for Epidermolysis bullosa

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Epidermolysis bullosa
Title Recruitment status Location
Safety Study of Gene-modified Autologous Fibroblasts in Recessive Dystrophic Epidermolysis Bullosa Recruiting United Kingdom
Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa Recruiting United Kingdom
ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa Recruiting United Kingdom
Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) Recruiting United Kingdom
Allogeneic fibroblast cell therapy for dystrophic epidermolysis bullosa Not Recruiting United Kingdom
Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa Not recruiting United Kingdom
Double blind, placebo controlled crossover study of the efficacy and side effects of low dose amitriptyline treatment for chronic pain, disordered sleep and reduced mobility in children with Epidermolysis Bullosa Not Recruiting United Kingdom
Study to evaluate the use of allogeneic mesenchymal stromal cells for the treatment of skin disease in children with recessive dystrophic epidermolysis bullosa Not Recruiting United Kingdom
Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa Not recruiting United Kingdom
A prospective placebo controlled phase II study to evaluate the use of allogeneic fibroblasts for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa. - Fibroblast cell therapy for RDEB - a phase II clinical trial Authorised United Kingdom

Page last reviewed:

Next review due: